Clinical Trial Update: Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of bendamustine with ixazomib and dexamethasone in relapsed/refractory multiple myeloma completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bendamustine (Bendamustine)
• DEXAMETHASONE (Dexamethasone)
• ixazomib (ixazomib)

Snippet

Sponsor: Parameswaran Hari | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-01-27